2nd European Cancer Dependency Map Symposium

Submission Deadline: 18/09/2025

Type of event/activity: 2nd European Cancer Dependency Map Symposium

Description/Purpose:

Human Technopole (HT) is opening a Call for sponsors to support the 2nd European Cancer Dependency Map Symposium, which      will take place on November 20^th, 2025, at HT in Milan, Italy.

The European Cancer Dependency Map (EuroDepMap) is an emerging and heterogeneous community of European scientists committed to accelerating precision cancer medicine by systematically identifying cancer dependencies and new therapeutic      targets for cancer treatment. This effort builds on the foundational work of the Broad Institute and the Sanger Institute, whose pioneering DepMap initiatives set the stage for large-scale functional genomics in cancer. It also directly responds to the call published in Nature in 2021, which advocated for a globally coordinated and federated approach to cancer dependency mapping.

The 1st European Cancer Dependency Map Symposium was organised at Human Technopole in 2023 by the Group Leader Francesco Iorio, in collaboration with leading scientists from EMBL-EBI (Cambridge, UK), Wellcome Sanger Institute (Cambridge, UK), and ETH Zürich (Zurich, CH), to increase the visibility of the EuroDepMap project and foster collaboration. This year’s Symposium renews the joint effort of these institutes, intending to convene world-leading experts in the fields of chemo-genomics and genome-editing screens to advance the discovery of new cancer vulnerabilities and therapeutic targets.

The Symposium will consist of on-site lectures by internationally renowned speakers, an extended panel discussion with experts from industry and an editor from Nature Genetics, as well as three short poster sessions. The event will be open to up to 120 participants with a particular focus on early-career scientists, and dedicated networking sessions will provide unique opportunities for training and interaction.

The 2nd Cancer Dependency Map Symposium offers a unique opportunity to explore cutting-edge advances and gain forward-looking insights into the systematic identification of tumour vulnerabilities and their exploitation for personalised anti-cancer therapies. A feature of this year’s programme is a dedicated segment on AI tools and advanced computational approaches.

Sponsoring the 2nd European Cancer Dependency Map Symposium will offer your company a strategic opportunity to stay at the forefront of oncology research, connect with leading experts in cancer genomics and functional screening, and showcase your commitment to advancing innovation in precision medicine. Your contribution will foster international collaboration among talented scientists and promote their research towards the development of new tools.

TOTAL COST OF THE EVENT: 31,000 EUR

Date: 20/11/2025

Duration: 1 day

Venue: Human Technopole, Milan, Italy

Sponsor’s requirements:

The Sponsors shall:

• Share HT’s vision of contributing to improving human health and well-being;
• Not be under proceedings linked to financial difficulties (e.g., insolvency/bankruptcy);
• Accept the placement of their logo together with other logos (co-sponsorships)
• Meet the general requirements set out in Article 94 of Italian Legislative Decree 36/2023
• In a later stage of the procedure, fill-in and sign the declarations pursuant to articles 94-98 of the Italian Legislative Decree no. 36/2023. Before submitting your application, you are kindly requested to review the template in the Section “Download” and address any questions for clarification to [email protected])